De-risking psychedelics: Compass Pathways, Cybin and Atai
Jan 9, 2024
48:12
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Alex Carchidi updates us on the psychedelic sector and what critical catalysts are approaching (1:30). Why Compass Pathways, Cybin, and Atai make the most sense for investors at this point (15:00). Pros and cons of 4 main industry stocks, including MindMed (29:50).
The Cannabis Investing Podcast